Launched a full-service health care consultative company that specializes in strategic multichannel solutionsrelated to Market Access, Patient Support Services, Sales Training for pharmaceutical and biotechnology brands.• Led strategic initiatives in collaboration with executive leadership to identify and capitalize on new businessopportunities while optimizing the profitability in current ventures.• Trained pharmaceutical regional and national account directors on understanding how to effectively pull through and engagewith payer clients and compliantly collaborate with patient support services.• Assisted physician offices in understanding patient prescription pathways, medical/pharmacy policy requirementspatient support, and improving communication with PBMs, retail and specialty pharmacies, and drug manufacturers.• Led customer payer contract negotiations, collaborated with sales and marketing teams to develop compelling valuepropositions and strategic initiatives to secure new payer/provider customers.• Leveraged data analytics, and other sales resources to inform decision making, optimize sales performanceand drive network success.• Utilized in-depth knowledge of the US payer landscape, integrated healthcare systems, and market dynamics to crafttargeted market access strategies resulting in securing preferred formulary access, sustaining market share growth, andfostering enduring partnerships with payers and key opinion leaders (KOLs).• Prepared clients to succeed in pre- and post-launch settings in niche markets, including orphan drugs by strategizingcustom campaigns that won payer, provider, consumer buy-in.

• Spearhead and led teams cross-functionally for the successful launch of Strata Select in the US market.• Communicated and built trustworthy relationships with members of CMS, AMA, MolDx, and VC's to enable the highest reimbursement established with CMS, and approval of ADLT.• Penetrated the previously untapped commercial market by developing the first value based contract with BCBS MI• Member of Executive Leadership team aligning relationships with One Oncology, The US Oncology Network, and multiple Academic Institutions.

• Championed organic growth initiatives to transform the U.S. and Managed Markets division into a sales powerhouse, successfully amplifying gross revenue by 65% in one year on behalf of Rural Populations• Harnessed hands-on leadership tactics to empower employees and build a team of collaborative, top performers, strategically mentoring all 50 employees to succeed and warrant client satisfaction.• Analyzed RFP’s while creating QBR’s for client performance.• Led all negotiations with multiple payers and advocacy teams

• Pioneered account management strategies to serve as the lead for the U.S. Payer Stratagies for SP, IVC, and Provider Groups• Negotiated and executed 54 contracts with multiple private and commercial payers• Directly managed team members consisting of i.e.; Directors of National Accounts, Benefits Investigation,and Infusion Centers• Directed the integration and alignment of numerous affiliate agencies to stabilize revenue streams, strategically weaving together consumer, digital, medical education, and social media promotion.• Strategically aligned company goals for acquisition through payer partnerships and licensing

• Combined cumulative experience of developing direct to payer, provider, and consumer marketing strategies to innovate client deliverables that surpassed Plan of Action (POA) expectations and attracted repeat business.• Succeeded in driving revenue growth across the company’s entire brand portfolio by devising competitive intelligence-driven strategies and delivering persuasive sales pitches to stakeholders that consistently won buy-in, effectively increasing the scope of work (SOW) by 200% within a two-month timeframe.• Crafted a proactive campaign, a budget impact model, and the pull through activities to successfully prepare clients for legislative and reimbursement changes, positioning clients for optimal formulary access and productuptake.• Designed and established the first client-facing Managed Markets Contracting to distribute on a quarterlybasis that focused on Medicare, Medicaid, and health reform initiatives.

• Led and strategically navigated all contracting and provider relations activities to ensure the quality delivery of Managed Care services for 208K+ Medicaid and Medicare members across the United States.• Aligned all systems, formulary and medical policies, contracts, and reimbursement schedules within United States• Orchestrated a financial analysis of revenue projections based on contractual rates with payers, adverse trends, terms, and appropriate recommendations to safeguard regulatory contract and compliance.• Executed 76 specialty contracts within 18 months• Aligned company for acquisition and merger

• Led all aspects of Managed Care , Trade, and Distribution contract negotiations• Led all Strategic Partnerships with PharmaceuticalManufacturers• 340B Contract Negotiations• Executed compliance in accordance to specialty pharmacy regulations• Executed over 54 contracts based on "loss leaders", financial analysis• Spearhead the M&A for continuous growth opportunities• Member of Executive Board and led direct reports

• Launched Xeomin successfully in US for Cervical Dystonia• Led all thought leader strategic sessions i.e.; Hubs, PAP,Advocacy, and 340B• Lead a team of 5 FRM'S and 6 NAM'S to successfully achieve formulary status• Negotiated all Buy and Bill and Wholesale arrangements• Lobbied on Capitol Hill with the President of AAN (Spoke directly to Congress)

-Promoted 3 times throughout my career with Express Scripts-Led Managed Care strategies and negotiations -Led PBM Employer Group presentations and contracting-Executed "preferred / exclusive " status through RFP submissions and negotiations -Managed multiple specialty pharmacy partnerships in all specialty disease states Government Affairs andnamed to Thought Leader Committee-Prepared P&L with senior leadership for Wall Street-Executed managed care contracts and RFO oversight -Managed over $500 million in revenue, and up to $1 billion

• Product Launch and sales strategy for multiple specialty therapies• GPO Contract Negotiations• Buy and Bill "Thought Leader"• Named to "Oncology Leadership Team"• Exceeded targets YOY BY 115% to 189%• Exceeded $60 million with 6.3% growth